Illuma Labs, a pioneering force in voice authentication technology for banking institutions, has successfully closed a $9 million Series A funding round. The investment, led by LiveOak Ventures and supported by Forefront Venture Partners, Curql Fund, UsNet, Capital Factory, Connexus, and TDECU, will drive the company’s efforts to develop cutting-edge solutions to tackle fraud, voice…
In an industry where leasing churn has long been treated as an inevitable cost of doing business, Renew is making a bet: what if that churn could become a competitive lever instead of a hemorrhage? With a freshly closed $12 million Series A round led by Haymaker Ventures and backed by Goldcrest Capital, Upfront Ventures,…
In a groundbreaking move for the beauty and wellness industry, Fresha, the world’s leading marketplace platform for beauty services, has announced a strategic investment in Yuv, a pioneering company specializing in AI-powered hair color technology. This partnership promises to reshape the hair coloring experience for salons and clients alike, enhancing both service quality and operational…
Neuspera Medical, a company pioneering a discreet and minimally invasive treatment for overactive bladder (OAB), has secured $23 million in Series D financing. This significant investment round, led by Vertex Ventures HC and Treo Ventures, will propel Neuspera’s Neuspera System through U.S. Food and Drug Administration (FDA) premarket approval (PMA) and towards commercialization. OAB, a…
In a significant advancement for cancer treatment, Brenus Pharma has announced the successful completion of a $25 million Series A financing round, aimed at accelerating the development of its precision cancer vaccines. This round was led by a consortium of French investors, in partnership with Belgian investment funds, and will primarily fund the first Phase…
LifeSpan Vision Ventures has made a significant investment in Remedium Bio, a biotechnology firm renowned for its groundbreaking gene therapy platform, Prometheus™. This latest funding is set to propel Remedium Bio’s innovative approach to gene therapy into new realms of clinical research and application. Remedium Bio is at the forefront of biotechnology with its Prometheus™…
In a significant advancement for ophthalmic medicine, RevOpsis Therapeutics, a pioneering biopharmaceutical firm, has been awarded a Small Business Innovation Research (SBIR) grant exceeding $1.8 million from the National Eye Institute (NEI), part of the National Institutes of Health (NIH). This funding will bolster the development of their lead asset, RO-104, aimed at treating neovascular…
Gendo, a pioneering generative AI platform tailored for architects, has secured $1.1 million in funding and unveiled its innovative technology to the world. Founded by architectural designer George Proud and software engineer Will Jones, Gendo emerges from stealth mode with a mission to transform architectural design processes through AI-driven visualizations. Traditional methods of creating architectural…
In a pivotal moment for the materials industry, Australian start-up Uluu has secured AU$16 million in its Series A funding round to build a demonstration facility capable of scaling its seaweed-derived plastic alternative. Headquartered in Perth, Western Australia, the company plans to move from its current 100 kg/year pilot plant to a 10-tonne/year demonstration plant…
Lario Therapeutics, a pioneering biopharmaceutical firm dedicated to advancing precision medicines for epileptic and neurological disorders, has been awarded a substantial $6 million USD grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). This funding is earmarked to propel Lario’s preclinical research into CaV2.3 calcium channel inhibitors, heralded as a novel approach to…
